The Scientist

» drug development and ecology

Most Recent

image: Lazarus Drugs

Lazarus Drugs

By | February 1, 2015

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.  

1 Comment

image: Screening Goes In Silico

Screening Goes In Silico

By | February 1, 2015

Computational tools take some of the cost—and guesswork—out of drug discovery.

0 Comments

image: Drug Stimulates Brown Fat

Drug Stimulates Brown Fat

By | January 28, 2015

A small study finds that an approved medication increases metabolic rate and the activity of thermogenic brown fat in men.

2 Comments

image: IOM Urges Data Sharing

IOM Urges Data Sharing

By | January 15, 2015

The Institute of Medicine says results from human clinical trials ought to be made available to independent researchers within 18 months.

0 Comments

image: Shire Makes $5.2 Billion Buy

Shire Makes $5.2 Billion Buy

By | January 13, 2015

The Irish drugmaker moves on from its terminated sale to AbbVie to purchase New Jersey-based NPS Pharmaceuticals.

0 Comments

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

image: Two Chemists Knighted

Two Chemists Knighted

By | January 2, 2015

Researchers who contributed to the development of Viagra and produced “greener” solvents, respectively, achieved knight status from the Queen of England.

0 Comments

image: Taming Bushmeat

Taming Bushmeat

By | January 1, 2015

Chinese farmers’ efforts at rearing wild animals may benefit conservation and reduce human health risks.

1 Comment

image: Bats Make a Comeback

Bats Make a Comeback

By | December 22, 2014

Citizen-scientist data obtained through the U.K.’s National Bat Monitoring Programme show that populations of 10 bat species have stabilized or are growing.

0 Comments

image: Layoffs, Restructuring at GSK

Layoffs, Restructuring at GSK

By | December 4, 2014

GlaxoSmithKline is eliminating 900 US jobs—most in R&D.

0 Comments

Popular Now

  1. Opinion: Making Progress by Slowing Down
  2. How Fats Influence the Microbiome
  3. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  4. Influential Cancer Biologist Dies
Advertisement
NeuroScientistNews
NeuroScientistNews
Advertisement